Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Firms May Lose Data Exclusivity Earlier Under Planned EU Adaptive Licensing Regime

This article was originally published in The Pink Sheet Daily

Executive Summary

Adaptive licensing is coming to Europe and, while it will be beneficial to patients, data exclusivity considerations may render it a double-edged sword to the innovative drug industry.

You may also be interested in...

Cancer Drug Cull By NHS Sparks Demands For NICE Reform

Disappointed by NHS England’s decision to remove a number of high-cost drugs from the Cancer Drugs Fund, the U.K. pharma industry is focusing its firepower on reforming NICE appraisals.

Adapting HTA To A Value-Based Approach: A Conversation With ABPI's Stephen Whitehead

The Association of the British Pharmaceutical Industry's chief executive says a focus on drug value rather than cost, and an adaptive approach to health technology assessment are approaches that would encourage pharma innovation.

Europe Unveils New Health Commissioner And Restructuring For Growth

The EU’s new Health Commission Vytenis Andriukaitis will need to focus on growth and competitiveness, as the new Commission redistributes responsibility for pharmaceuticals.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts